Intech Investment Management LLC bought a new position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,596 shares of the company’s stock, valued at approximately $207,000.
A number of other large investors have also bought and sold shares of AVNS. KBC Group NV boosted its position in shares of Avanos Medical by 63.0% during the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after purchasing an additional 1,095 shares in the last quarter. Canada Pension Plan Investment Board bought a new position in Avanos Medical in the second quarter worth approximately $70,000. XTX Topco Ltd acquired a new stake in Avanos Medical in the second quarter valued at approximately $202,000. Magnetar Financial LLC bought a new stake in shares of Avanos Medical during the second quarter valued at approximately $248,000. Finally, Caxton Associates LP raised its position in shares of Avanos Medical by 13.6% during the second quarter. Caxton Associates LP now owns 17,035 shares of the company’s stock worth $339,000 after purchasing an additional 2,034 shares during the period. 95.17% of the stock is currently owned by institutional investors and hedge funds.
Avanos Medical Stock Performance
Shares of Avanos Medical stock opened at $18.47 on Friday. The company has a market cap of $848.88 million, a PE ratio of 54.32 and a beta of 0.95. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a 52 week low of $17.39 and a 52 week high of $25.36. The business has a 50 day moving average price of $20.77 and a 200-day moving average price of $21.47.
Analysts Set New Price Targets
Read Our Latest Report on AVNS
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Stories
- Five stocks we like better than Avanos Medical
- What Are the U.K. Market Holidays? How to Invest and Trade
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- What is a Low P/E Ratio and What Does it Tell Investors?
- 10 Safe Investments with High Returns
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.